Skip to content

Journal · Inflammation · Updated 21 November 2026

Inflammation Research

Read Inflammation Research articles on DeepDyve. No university library needed.

Inflammation Research covers the biology of inflammation and its role in disease, with recent papers on sepsis, immune checkpoints, cell death and macrophages in bone repair. Springer Nature publishes it. It was previously published as Agents and Actions. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Inflammation Research
Journal cover

Inflammation Research at a glance

Full title
Inflammation Research
Former title
Agents and Actions
Abbreviation (NLM)
Inflamm Res
Publisher
Springer Nature
Print ISSN
1023-3830
Online ISSN (eISSN)
1420-908X
Current title since
1995
Subjects
Allergy and Immunology, Pathology
Access model
Hybrid (29% free to read in 2026)

Ways to access Inflammation Research

29% of the articles Inflammation Research published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 29% of Inflammation Research articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Inflammation Research. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Inflammation Research articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Impact factor and metrics

Inflammation Research’s 2025 Journal Impact Factor is 6.2, and its 5-year Impact Factor is 6.2.

6.2

Journal Impact Factor (2025)

6.2

5-year Impact Factor (2025)

12 days

Median time to first decision

Source: journal metrics on the Inflammation Research homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.

Recent Inflammation Research research worth reading

Published January to May 2026. Summaries describe what the authors report.

  1. Open accessSepsis · Burns

    Longitudinal biomarker trajectories and their prognostic utility for 21-day mortality in burn patients with sepsis: a retrospective cohort study

    Tracking 15 biomarkers over 21 days in 943 burn patients with sepsis, the authors identified three patient phenotypes with mortality of 5.2%, 18.7% and 38.0%, and found that only the Burn Index remained an independent risk factor in multivariate analysis.

    Lou et al. · Inflammation Research, published online January 21, 2026 · DOI 10.1007/s00011-025-02178-2

  2. LitStreamDiabetic osteoporosis · Macrophages

    Melatonin improves osteogenic differentiation in a high-glucose environment by activating NRF2 to promote autophagy through the regulation of cross-talk between macrophages and bone marrow mesenchymal stem cells

    The authors report that under high glucose, melatonin did not directly drive bone-forming differentiation of mesenchymal stem cells but did so indirectly by pushing macrophages toward the M2 phenotype through NRF2-driven autophagy, and that high doses eased diabetic osteoporosis in mice.

    Zhang et al. · Inflammation Research, published online May 7, 2026 · DOI 10.1007/s00011-026-02267-w

  3. LitStreamSepsis · Coagulopathy

    Endotheliopathy within the thromboinflammatory network of sepsis-induced coagulopathy

    The authors review how damage to the blood vessel lining interacts with platelets, neutrophils and monocytes to drive sepsis-induced coagulopathy, and discuss endothelial biomarkers and emerging therapies such as Tie2 agonists, heparanase inhibitors and thrombomodulin supplementation.

    Iba et al. · Inflammation Research, published online March 17, 2026 · DOI 10.1007/s00011-026-02204-x

  4. LitStreamImmune checkpoints · Immunotherapy

    Immune checkpoint molecules beyond PD-1 and CTLA-4: emerging targets in autoimmune diseases and cancer immunotherapy

    The authors review immune checkpoints beyond PD-1 and CTLA-4, such as LAG-3, TIM-3, TIGIT and VISTA, covering next-generation inhibitors to overcome resistance in cancer and agonistic checkpoint modulation as a targeted immunosuppressive approach in autoimmune disease.

    Dadfar et al. · Inflammation Research, published online March 17, 2026 · DOI 10.1007/s00011-026-02211-y

  5. LitStreamSepsis · Cell death

    Regulated cell death in sepsis: reframing NETosis within the spectrum of apoptosis and inflammatory lytic death

    The authors review regulated cell death in sepsis, arguing that pyroptosis and necroptosis amplify early hyperinflammation, apoptosis drives late immune depletion, and NET formation is better seen as an effector mechanism linking innate immunity to thromboinflammation than as a main death program.

    Iba et al. · Inflammation Research, published online April 28, 2026 · DOI 10.1007/s00011-026-02261-2

See every Inflammation Research article on DeepDyve

Questions about Inflammation Research

How can I read Inflammation Research articles without a subscription?

29% of Inflammation Research articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Inflammation Research articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Inflammation Research?

Inflammation Research’s NLM (PubMed) abbreviation is Inflamm Res.

What is the ISSN of Inflammation Research?

The print ISSN is 1023-3830 and the online ISSN is 1420-908X.

What is the impact factor of Inflammation Research?

Inflammation Research’s Journal Impact Factor is 6.2 (2025), and its 5-year Impact Factor is 6.2, according to Springer Nature’s published metrics.

Is Inflammation Research open access?

Inflammation Research is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 72 of 249 Inflammation Research articles (29%) carry a Creative Commons license, per Crossref.

Inflammation Research articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.

Start reading Inflammation Research today

One month free, then less than $2 a day. Inflammation Research, plus millions of articles from thousands of journals.

Start free month

Like this: